Middle East Medicinal Plants in the Treatment of Diabetes: A Review

The document from January 31, 2021, reviewed the antidiabetic properties of medicinal plants from the Middle East, emphasizing their potential as treatments for diabetes. It highlighted the limitations of current antidiabetic therapies and the need for more research on the active compounds, mechanisms, safety, and pharmacokinetics of these plants. The review provided details on specific plants and their effects on blood glucose levels and potential action mechanisms. It also discussed the effectiveness of these plants in animal models, noting their ability to reduce blood glucose levels, enhance insulin secretion, and provide antioxidant effects. Some extracts were found to be more effective than the antidiabetic drug glibenclamide. The review called for further research to scientifically validate the traditional use of these plants and to explore their potential as a foundation for new antidiabetic treatments.